Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RNA Positive”

1,121 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,121 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05547464
What this trial is testing

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers

Who this might be right for
Tuberculosis
BioNTech SE 497
Not applicableStudy completedNCT01910493
What this trial is testing

Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique

Who this might be right for
HIV-positive
Absolute Return for Kids 1,352
Testing effectiveness (Phase 2)Study completedNCT00002235
What this trial is testing

A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 6
Early research (Phase 1)UnknownNCT00002449
What this trial is testing

Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy

Who this might be right for
HIV Infections
Chiron Corporation 212
Not applicableStudy completedNCT04725084
What this trial is testing

Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 355
Large-scale testing (Phase 3)Study completedNCT00002140
What this trial is testing

A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
Pfizer
Not applicableStudy completedNCT00000950
What this trial is testing

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT00170443
What this trial is testing

Trivalent rHA Dose Escalation Study in Elderly Subjects

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 399
Early research (Phase 1)Study completedNCT00086710
What this trial is testing

Study of Enfuvirtide in HIV-Positive Subjects

Who this might be right for
HIV InfectionsAIDS
Trimeris 26
Not applicableStudy completedNCT02535455
What this trial is testing

Acceptance and Compassion to Enhance Self-care Pilot

Who this might be right for
HIV/AIDSSubstance Use Disorder
University of California, San Francisco 10
Testing effectiveness (Phase 2)Study completedNCT00002171
What this trial is testing

Viracept in HIV-Positive Women

Who this might be right for
HIV Infections
Agouron Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00822315
What this trial is testing

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
ANRS, Emerging Infectious Diseases 155
Testing effectiveness (Phase 2)Study completedNCT03639311
What this trial is testing

Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study

Who this might be right for
HIV Infections
ViiV Healthcare 97
Large-scale testing (Phase 3)Study completedNCT00871000
What this trial is testing

Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

Who this might be right for
Acellular PertussisTetanusDiphtheria+1 more
GlaxoSmithKline 303
Not applicableStudy completedNCT00051519
What this trial is testing

Screening HIV-Infected Patients for Vaccine Studies

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 1,000
Testing effectiveness (Phase 2)Study completedNCT00002413
What this trial is testing

MKC-442 in HIV-Positive Patients

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Not applicableStudy completedNCT06806124
What this trial is testing

Impact of the Elevation Training Mask in CrossFit® Post-SARS-CoV-2 Infection.

Who this might be right for
COVID19- Infection with SARS-CoV-2 VirusSARS-CoV-2 Positive PatientsCOVID-19 Pulmonary Complications+1 more
University of Valladolid 20
Not applicableUnknownNCT04897646
What this trial is testing

The TELEAP1 CPAP-telemonitoring Study

Who this might be right for
Obstructive Sleep Apnea
University Hospital, Montpellier 300
Not applicableStudy completedNCT00582023
What this trial is testing

Role of Positive Affect in Adjustment to HIV

Who this might be right for
HIV Infections
University of California, San Francisco 160
Not applicableStudy completedNCT04033718
What this trial is testing

Inpatient Package to Reduce HIV and AIDS-related Death in Zambia

Who this might be right for
HIV/AIDSTransitions of CareHospitalization+3 more
University of Alabama at Birmingham 72
Next Page